WASHINGTON — The Biden administration announced last Tuesday it’s reinterpreting federal law to allow Medicare and Medicaid patients access to anti-obesity medications to reduce their weight over the ...
Research reports that in the United States, the number of patients who underwent bariatric procedure decreased by 25%, while ...
A new study finds people who take weight-loss drugs also cut back on alcohol consumption. Researchers think the drugs could ...
State measures now seek to remove barriers to weight-loss drugs, as demand for the meds skyrockets amid rising concerns about ...
The proposal would expand coverage of anti-obesity drugs to 7.5 million people covered by Medicare and Medicaid, the Biden ...
A study finds that anti-obesity medications may help reduce alcohol consumption, with nearly half of participants in weight ...
Nearly half of individuals consuming alcohol at baseline reduced their alcohol consumption following the initiation of AOMs.
Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.
Taking anti-obesity drugs has led some U.S. adults to throw away more food than they tossed before starting the medications, ...
Another study suggests that weight-loss meds like Wegovy (NVO) and Mounjaro (LLY) can help people cut back on drinking ...
The rise in obesity rates across the United States has brought increased attention to treatments aimed at addressing the ...
The Centers for Medicare and Medicaid Services proposed changes to reduce prescription drug costs for Medicare Advantage and ...